Indeed, 50% of non-treated GIST specimens stained for FGF-2 (n = 12) were negative for FGF-2 (Figure 7A—upper panel, B) or exhibited a weak cytoplasmic or membranous staining (Figure 7A, middle panel). The gene discussed is FGF2; the disease is gastrointestinal stromal tumor.